Dr. Sowmya Barrela, MD

Dr. Barrela practices at Wellstar North Fulton Medical Center in Roswell, Georgia, part of Wellstar Health System.

Dr. Barrela's NPI, 1811371461, was assigned on July 14, 2015. Dr. Barrela holds Georgia license 84028.

Dr. Barrela's primary practice is Wellstar North Fulton Medical Center, at 3000 Hospital Boulevard, Roswell, GA 30076 in Fulton County. The practice phone is (770) 751-2500.

Dr. Barrela's primary practice is Wellstar North Fulton Medical Center in Roswell, Georgia, part of Wellstar Health System. Dr. Barrela is also affiliated with Wellstar Cobb Medical Center. The medical group on file is Wellstar Medical Group. Dmand AI also links Dr. Barrela to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Barrela practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Barrela's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Barrela's licenses on file in 2 states: Georgia and Michigan.

CMS data shows 1,224 Medicare services from Dr. Barrela across 5 procedure codes in 2024, for 374 Medicare patients. Medicare paid $100,496 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 374 Medicare patients who saw Dr. Barrela in 2024. The largest group is 85 and over, with 141 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Barrela's median patient age at 78, with 57% women.

In 2024, Dr. Barrela wrote 477 Medicare Part D claims for 189 patients. 88% of them were for generic drugs. CMS names the drug for 222 of them, across 12 drugs with 11 or more claims each, at $13,589 in total drug cost. In 2023, CMS named 233 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Barrela for performance year 2024, reported through an alternative payment model (APM). Dr. Barrela accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 15 general payments to Dr. Barrela from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $138.